Loading data...

Psilocybin and psilocin research index

Find psilocybin and psilocin papers, preprints, trials, and citations with clear source context.

Searches titles, authors, journals, identifiers, indexed metadata, and derived research topics. Use Filters to narrow by source, status, substance, study type, or date.

Database 4,961 indexed records Auto-updated on Aug 19, 2026 01:24 UTC

Executed search Author: Bharti SAK 33 matching records are displayed.

Clear search

Database

4,742 Psilocybin Records 673 Psilocin Records 1,461 Journals 66 Research Topics

Published 4,223 Peer-reviewed / formal records Preprints 435 Marked as not peer reviewed Clinical trials 300 ClinicalTrials.gov records R toolkit visNetwork Bibliometrics, live SQLite analysis, HTML graph, and PDF export

Top journals 1,461 indexed journals

Journal	Records
Journal of psychopharmacology (Oxford, England)	148
Journal of psychoactive drugs	97
Frontiers in psychiatry	90
Psychopharmacology	85
Neuroscience Applied	57
Journal of Psychedelic Studies	48
Psychedelic medicine (New Rochelle, N.Y.)	39
Scientific reports	37
Biological Psychiatry	32
Journal of affective disorders	32

Research topics 66 topic filters

Depression 1,737 Receptor Pharmacology 1,281 Safety 1,203 Mechanism of Action 1,072 Review Article 1,072 Clinical Trial 977 Anxiety 883 Addiction 824 Pharmacology 752 General 538 Aging 524 Animal Study 524 Observational Study 515 Brain Imaging 481 Treatment-Resistant Depression 417 Emotional Processing 409 PTSD 400 Neuroplasticity 399

Source coverage 8 active sources

Source	Count	Share	Status
PubMed	2,566	51.7%	Active
OpenAlex	1,155	23.3%	Active
Crossref	405	8.2%	Active
ClinicalTrials.gov	300	6%	Active
Europe PMC	188	3.8%	Active
PsyArXiv	186	3.7%	Active
bioRxiv	123	2.5%	Active

Publication timeline 3,858 dated records

3,858 records since 2020

Annual records Cumulative line

Reset all

Keyword search Author

Substances Psilocybin 4742 Psilocin 673

Date range quick select Last month Last year Last 5 years All time Custom range

Executed search Author: Bharti SAK 33 matching records are displayed.

Clear search

Filtered publication index

Search results

33 matching records for Author: Bharti SAK.

Select for export

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1177/02698811221131997 PubMed 36515370

Journal of psychopharmacology (Oxford, England) 2023-01-01 Morton E, Sakai K, Ashtari A, Pleet M, Michalak EE, Woolley J

PubMed Published psilocybin Depression Anxiety Clinical Trial Clinical Trial More

Select for export

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1056/nejmoa2206443 PubMed 36322843

The New England journal of medicine 2022-11-03 Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC

PubMed Published psilocybin Depression Clinical Trial Treatment-Resistant Depression Clinical Trial More

Select for export

Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1055/a-1714-9097 PubMed 35045580

Pharmacopsychiatry 2022-07-01 Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H

PubMed Published psilocybin Depression Mechanism of Action Clinical Trial Systematic Review More

Select for export

"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1371/journal.pone.0279073 PubMed 36516137

PloS one 2022-01-01 DellaCrosse M, Pleet M, Morton E, Ashtari A, Sakai K, Woolley J

PubMed Published psilocybin Depression Addiction Emotional Processing Clinical Trial More

Select for export

Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.3390/ph14121213 PubMed 34959614

Pharmaceuticals (Basel, Switzerland) 2021-11-24 Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J

PubMed Published psilocybin Neuroplasticity Pharmacology Mechanism of Action Review Article More

Select for export

Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.12688/f1000research.28133.1

F1000Research 2021-03-15 Musikaphongsakul Prinya, Ya Kimheang, Subsoontorn Pakpoom, Lohitnavy Manupat

Crossref Published psilocybin psilocin Pharmacology Receptor Pharmacology Other More

Select for export

Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1037/pha0000253 PubMed 30628811

Experimental and clinical psychopharmacology 2019-06-01 Sakloth F, Leggett E, Moerke MJ, Townsend EA, Banks ML, Negus SS

PubMed Published psilocybin Depression Addiction Receptor Pharmacology Animal Study More

Select for export

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1177/0269881116678781 PubMed 27856683

Journal of psychopharmacology (Oxford, England) 2016-12-01 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR

PubMed Published psilocybin Depression Anxiety Consciousness Case Report More

Select for export

Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1248/bpb.b14-00315 PubMed 25342005

Biological ^|^ Pharmaceutical Bulletin 2015-01-01 Sakashita Yuichi, Abe Kenji, Katagiri Nobuyuki, Kambe Toshie, Saitoh Toshiaki, Utsunomiya Iku

Crossref Published psilocin Mechanism of Action Receptor Pharmacology Other More

Select for export

The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin

No abstract availability was recorded for this entry.

Details DOI 10.1016/j.drugalcdep.2014.09.060

Drug and Alcohol Dependence 2014-12-16 Frederick S. Barrett, Matthew P. Bradstreet, Jeannie-Marie Leoutsakos, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse

OpenAlex Published psilocybin Pharmacology Other More

Select for export

Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1111/j.1468-5906.2012.01685.x PubMed 23316089

Journal for the scientific study of religion 2012-12-01 Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR

PubMed Published psilocybin Spirituality Mystical Experience Other More

Select for export

ChemInform Abstract: A New Synthesis of Psilocin

Abstract available at the source but not redistributed here. Read at source.

Details DOI 10.1002/chin.199932235

ChemInform 1999-08-10 Sakagami Hideki, Ogasawara Kunio

Crossref Published psilocin General Other More

Select for export

A New Synthesis of Psilocin

No abstract availability was recorded for this entry.

Details DOI 10.3987/com-99-8492

HETEROCYCLES 1999-01-01 Ogasawara Kunio, Sakagami Hideki

Crossref Published psilocin General Other More